Japanese researchers eye COVID treatment derived from stem cells

OSAKA — A Japanese research team is developing an immunotherapy to treat COVID-19 using embryonic stem cells.

The researchers at Kyoto University, led by Hiroshi Kawamoto, have developed a way to genetically engineer embryonic stem cells to produce killer T cells, a type of white blood cell that can search for and destroy infected cells in the body.